EUVIMEDEUVIMED entdecken
Crossref

Elevated lactate aggravates insulin resistance by downregulating the PI3K/AKT/GLUT2 pathway in type 2 diabetes mellitus

Bing-Yan Wei, Xiao-Chan Zuo, Cheng-Shuang Feng, Xiao-Sen Shang, Yi-Chun Yang, Rui-Hu Zhang, Ze-Ya Shi, Wen-Tao Wang, Jian-Qin Wu, Hai-Long Wang, Xi-Hua Yang, Guo-Hua Song und 1 weitere

Life Sciences · 2026-06 · 395 · 124368

DOI: 10.1016/j.lfs.2026.124368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Sciences, 2026-06. Verfasst von Bing-Yan Wei und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Animal Center, Shanxi Key Laboratory of Experimental Animal Science and Animal Model of Human Disease, Shanxi Medical University, Taiyuan,…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin Resistance, Proto-Oncogene Proteins c-akt, Glucose Transporter Type 2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Science and Technology Development Fund, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Type 2 diabetes mellitus (T2DM), a hyperglycemic metabolic disorder, is driven by progressive insulin secretion deficiencies and insulin resistance (IR). Lactate, a product of glycolysis, has also been found to be involved in regulating insulin-linked signaling pathways via lactylation, a novel post-translational modification that couples metabolic flux to protein mediator expression. However, the association between lactate and lactylation with IR is still largely unknown. MATERIALS AND METHODS: Serum lactate and hepatic lactylation levels, as well as their effects on IR, were investigated among T2DM patients, in vitro HepG2 cell and in vivo diabetic animal (Chinese hamster, db/db mice) models. Rotenone (ROT) and dichloroacetate (DCA) were used to pharmacologically upregulate and downregulate lactate/lactylation levels, respectively. KEY FINDINGS: T2DM patients had significantly higher serum lactate and hepatic lactylation levels than non-diabetics. Furthermore, increased lactate/lactyation corresponded to lowered HepG2 glucose uptake in vitro, as well as higher fasting blood glucose and Homeostatic Model Assessment of Insulin Resistance scores in Chinese hamsters and mice in vivo. Moreover, increasing lactate/lactylation levels with ROT was linked to downregulation of phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/Glucose Transporter 2 (GLUT2) signaling, which plays a key role in insulin-mediated glucose homeostasis. This downregulation, in turn, exacerbated IR. On the other hand, lowering lactate/lactylation levels with DCA upregulated PI3K/AKT/GLUT2 expression and alleviated IR. SIGNIFICANCE: All these findings suggested that higher lactate and lactylation exacerbated IR via suppressing PI3K/AKT/GLUT2. Therefore, modulating lactate levels could serve as a potential approach for treating IR in T2DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Insulin ResistanceProto-Oncogene Proteins c-aktGlucose Transporter Type 2Lactic AcidAnimalsHumansSignal TransductionMaleMiceCricetinaeDown-RegulationHep G2 CellsPhosphatidylinositol 3-KinasesMiddle AgedCricetulusFemalePhosphatidylinositol 3-KinaseDiabetes Mellitus, Experimental

Stichwörter der Autor:innen

Glucose transporter 2Insulin resistanceLactateLactylationPhosphatidylinositol 3-kinaseProtein kinase B/AKTType 2 diabetes mellitus

Substanzen

Proto-Oncogene Proteins c-aktGlucose Transporter Type 2Lactic AcidPhosphatidylinositol 3-KinasesPhosphatidylinositol 3-Kinase

Autor:innen und Institutionen

  • Laboratory Animal Center, Shanxi Key Laboratory of Experimental Animal Science and Animal Model of Human Disease, Shanxi Medical University, Taiyuan, 030001, China.
  • School of Basic Medicine, Basic Medical Science Center, Shanxi Medical University, Jinzhong, 030600, China.
  • Department of Cardiology of Taiyuan Central Hospital, Taiyuan, 030009, China.
  • School of Basic Medicine, Basic Medical Science Center, Shanxi Medical University, Jinzhong, 030600, China. Electronic address: longwty@163.com.
  • Laboratory Animal Center, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, 030013, Chin…
  • Laboratory Animal Center, Shanxi Key Laboratory of Experimental Animal Science and Animal Model of Human Disease, Shanxi Medical University, Taiyuan, 030001, China. Electronic address: ykdsgh@163.com.

Förderung

  • Science and Technology Development Fund
  • National Natural Science Foundation of China

Zitieren

APA

Wei, B. Y., Zuo, X. C., Feng, C. S., Shang, X. S., Yang, Y. C., Zhang, R. H., Shi, Z. Y., Wang, W. T., Wu, J. Q., Wang, H. L., Yang, X. H., Song, G. H., & Chen, Z. Y. (2026). Elevated lactate aggravates insulin resistance by downregulating the PI3K/AKT/GLUT2 pathway in type 2 diabetes mellitus. Life Sciences, 395, 124368. https://doi.org/10.1016/j.lfs.2026.124368

Vancouver

Wei BY, Zuo XC, Feng CS, Shang XS, Yang YC, Zhang RH, et al. Elevated lactate aggravates insulin resistance by downregulating the PI3K/AKT/GLUT2 pathway in type 2 diabetes mellitus. Life Sciences. 2026;395:124368. doi:10.1016/j.lfs.2026.124368

BibTeX
@article{Wei2026,
  author = {Wei, Bing-Yan and Zuo, Xiao-Chan and Feng, Cheng-Shuang and Shang, Xiao-Sen and Yang, Yi-Chun and Zhang, Rui-Hu and Shi, Ze-Ya and Wang, Wen-Tao and Wu, Jian-Qin and Wang, Hai-Long and Yang, Xi-Hua and Song, Guo-Hua and Chen, Zhao-Yang},
  title = {Elevated lactate aggravates insulin resistance by downregulating the PI3K/AKT/GLUT2 pathway in type 2 diabetes mellitus},
  journal = {Life Sciences},
  year = {2026},
  volume = {395},
  pages = {124368},
  doi = {10.1016/j.lfs.2026.124368}
}
Kostenlos starten →